North American Spine and Pain has announced the introduction of a new clinical approach to back pain management, expanding its suite of interventional treatments designed to address chronic and acute ...

Please provide your email address to receive an email when new articles are posted on . Liposomal bupivacaine was associated with less required opioids after spinal fusion vs. a control group. Length ...

Spinal manipulation alone was no more effective than guideline-recommended medical care for low back pain (LBP), results of a randomized comparison study showed. Of the first-line nonpharmacologic ...

Dr. Nicholas Theodore will discuss NOCISCAN's innovative use of MR Spectroscopy and AI for chronic low back pain at the Spine Summit. Aclarion, Inc. announced its participation in the 2025 Spine ...

Ann Arbor startup builds on global momentum as flagship product addresses widespread issue caused by prolonged sitting.

Please provide your email address to receive an email when new articles are posted on . Chronic low back pain is one of the most frequent and challenging conditions encountered in primary care.

Studies indicate that a majority of pharmacologic treatment modalities currently used for acute and subacute low back pain have shown little to small effect on patients’ pain levels and functional ...

From findings on opioid use, prior authorization and spine navigation, here are 10 key studies Becker’s reported on in the first quarter of 2026. 1. Carlsmed’s aprevo implant for lumbar spine surgery ...

The trajectory of outpatient spine surgery continues, some of the unexpected shifts ahead could come from developments in AI, ...

Chronic back pain affects millions, but simple solutions are within reach.